Nembutal®

Print

Nembutal® CII Sodium Solution (pentobarbital sodium injection, USP)

As of December 22, 2011, Nembutal was sold to Oak Pharmaceuticals, a subsidiary of Akorn, Inc.  For access to Akorn’s website for Nembutal please click here.

Important Contact Information

You are encouraged to report negative side effects to the FDA.
Visit www.fda.gov/medwatch, or call
1-800-FDA-1088.

You have chosen to visit another Lundbeck website or a third-party website, which is provided as a service to you. Lundbeck Inc. does not control content on third-party websites and cannot make representations concerning the accuracy of information on every website you visit. Lundbeck Inc. is not responsible for the privacy policy of any third-party website. We encourage you to read the privacy policy of every website you visit. Click OK to continue or Cancel to return to Lundbeck Inc.